275 related articles for article (PubMed ID: 34272849)
1. Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
Thornton PS; Maniatis AK; Aghajanova E; Chertok E; Vlachopapadopoulou E; Lin Z; Song W; Christoffersen ED; Breinholt VM; Kovalenko T; Giorgadze E; Korpal-Szczyrska M; Hofman PL; Karpf DB; Shu AD; Beckert M
J Clin Endocrinol Metab; 2021 Oct; 106(11):3184-3195. PubMed ID: 34272849
[TBL] [Abstract][Full Text] [Related]
2. Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial.
Maniatis AK; Nadgir U; Saenger P; Reifschneider KL; Abuzzahab J; Deeb L; Fox LA; Woods KA; Song W; Mao M; Chessler SD; Komirenko AS; Shu AD; Casella SJ; Thornton PS
Horm Res Paediatr; 2022; 95(3):233-243. PubMed ID: 35263755
[TBL] [Abstract][Full Text] [Related]
3. Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
Sävendahl L; Battelino T; Brod M; Højby Rasmussen M; Horikawa R; Juul RV; Saenger P;
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1847-61. PubMed ID: 31917835
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results.
Maniatis AK; Casella SJ; Nadgir UM; Hofman PL; Saenger P; Chertock ED; Aghajanova EM; Korpal-Szczyrska M; Vlachopapadopoulou E; Malievskiy O; Chaychenko T; Cappa M; Song W; Mao M; Mygind PH; Smith AR; Chessler SD; Komirenko AS; Beckert M; Shu AD; Thornton PS
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2680-e2689. PubMed ID: 35428884
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
Deal CL; Steelman J; Vlachopapadopoulou E; Stawerska R; Silverman LA; Phillip M; Kim HS; Ko C; Malievskiy O; Cara JF; Roland CL; Taylor CT; Valluri SR; Wajnrajch MP; Pastrak A; Miller BS
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2717-e2728. PubMed ID: 35405011
[TBL] [Abstract][Full Text] [Related]
6. Long-Acting C-Terminal Peptide-Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children.
Zelinska N; Iotova V; Skorodok J; Malievsky O; Peterkova V; Samsonova L; Rosenfeld RG; Zadik Z; Jaron-Mendelson M; Koren R; Amitzi L; Raduk D; Hershkovitz O; Hart G
J Clin Endocrinol Metab; 2017 May; 102(5):1578-1587. PubMed ID: 28323965
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.
Chatelain P; Malievskiy O; Radziuk K; Senatorova G; Abdou MO; Vlachopapadopoulou E; Skorodok Y; Peterkova V; Leff JA; Beckert M;
J Clin Endocrinol Metab; 2017 May; 102(5):1673-1682. PubMed ID: 28201598
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients.
Miller BS; Yuen KCJ
Drug Des Devel Ther; 2022; 16():2055-2066. PubMed ID: 35791404
[TBL] [Abstract][Full Text] [Related]
9.
Gomez R; Khadilkar V; Shembalkar J; Chu DM; Ko CW; Wajnrajch MP; Wang R
J Pediatr Endocrinol Metab; 2024 Jun; 37(6):525-531. PubMed ID: 38717038
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.
Horikawa R; Tanaka T; Hasegawa Y; Yorifuji T; Ng D; Rosenfeld RG; Hoshino Y; Okayama A; Shima D; Gomez R; Pastrak A; Castellanos O
Horm Res Paediatr; 2022; 95(3):275-285. PubMed ID: 35417909
[TBL] [Abstract][Full Text] [Related]
11. Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency.
Lin Z; Shu AD; Bach M; Miller BS; Rogol AD
J Endocr Soc; 2022 Jan; 6(1):bvab168. PubMed ID: 34913019
[TBL] [Abstract][Full Text] [Related]
12. Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial.
Miller BS; Blair JC; Rasmussen MH; Maniatis A; Kildemoes RJ; Mori J; Polak M; Bang RB; Böttcher V; Stagi S; Horikawa R
J Clin Endocrinol Metab; 2022 Nov; 107(12):3378-3388. PubMed ID: 36062966
[TBL] [Abstract][Full Text] [Related]
13. An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment.
Zadik Z; Zelinska N; Iotova V; Skorodok Y; Malievsky O; Mauras N; Valluri SR; Pastrak A; Rosenfeld R
J Pediatr Endocrinol Metab; 2023 Mar; 36(3):261-269. PubMed ID: 36732285
[TBL] [Abstract][Full Text] [Related]
14. Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.
Battelino T; Rasmussen MH; De Schepper J; Zuckerman-Levin N; Gucev Z; Sävendahl L;
Clin Endocrinol (Oxf); 2017 Oct; 87(4):350-358. PubMed ID: 28656605
[TBL] [Abstract][Full Text] [Related]
15. TransCon human growth hormone for children with growth hormone deficiency: a technology evaluation.
Dos Santos JBR; Da Silva MRR
Expert Opin Drug Deliv; 2022 Jan; 19(1):1-7. PubMed ID: 34996331
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
17. Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH.
Miller BS; Blair JC; Rasmussen MH; Maniatis A; Mori J; Böttcher V; Kim HS; Bang RB; Polak M; Horikawa R
J Clin Endocrinol Metab; 2023 Nov; 108(12):3090-3099. PubMed ID: 37406251
[TBL] [Abstract][Full Text] [Related]
18. Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3.
Sävendahl L; Battelino T; Højby Rasmussen M; Brod M; Saenger P; Horikawa R
J Clin Endocrinol Metab; 2022 Apr; 107(5):1357-1367. PubMed ID: 34964458
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin.
Loftus J; Quitmann J; Valluri SR
Curr Med Res Opin; 2024 Feb; 40(2):175-184. PubMed ID: 38053515
[TBL] [Abstract][Full Text] [Related]
20. Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial.
Mori J; Ohata Y; Fujisawa Y; Sato Y; Röhrich S; Rasmussen MH; Bang RB; Horikawa R
Clin Endocrinol (Oxf); 2024 Apr; 100(4):389-398. PubMed ID: 38368603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
